Page 7 - Opgen News Today

StockNews.com upgraded shares of OpGen (NASDAQ:OPGN – Get Rating) from a sell rating to a hold rating in a research report report published on Tuesday morning. OpGen Stock Down 2.5 % Shares of OPGN opened at $0.69 on Tuesday. OpGen has a 52 week low of $0.55 and a 52 week high of $16.40. The […]

OpGen (NASDAQ:OPGN – Get Rating) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Tuesday. OpGen Stock Performance OPGN remained flat at $0.70 on Tuesday. 58,086 shares of the company traded hands, compared to its average volume of […]

Precigen, Inc. (NASDAQ:PGEN – Get Rating) – Equities researchers at HC Wainwright dropped their Q2 2023 earnings per share (EPS) estimates for shares of Precigen in a research report issued to clients and investors on Thursday, May 11th. HC Wainwright analyst S. Ramakanth now forecasts that the biotechnology company will post earnings of ($0.09) per […]

OpGen has reported a productive quarter marked by advancements across the board. Operating loss improved to $5.1m during the quarter (from $5.8m in Q122), driven by 94% y-o-y top-line growth (to $0.9m)

OpGen, Inc. (NASDAQ:OPGN – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 30th, there was short interest totalling 206,100 shares, an increase of 127.0% from the April 15th total of 90,800 shares. Approximately 3.8% of the shares of the stock are short sold. […]

Shares of Precigen, Inc. (NASDAQ:PGEN – Get Rating) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.34 and traded as low as $1.14. Precigen shares last traded at $1.18, with a volume of 980,821 shares trading hands. Analyst Ratings Changes PGEN has been the […]

ROCKVILLE, Md., May 01, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power...

The Manufacturers Life Insurance Company boosted its holdings in shares of Precigen, Inc. (NASDAQ:PGEN – Get Rating) by 96.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,234 shares of the biotechnology company’s stock after purchasing an additional 21,269 shares […]

OpGen, Inc. (NASDAQ:OPGN – Get Rating) saw a significant drop in short interest in March. As of March 31st, there was short interest totalling 303,400 shares, a drop of 44.4% from the March 15th total of 545,300 shares. Based on an average daily volume of 456,500 shares, the short-interest ratio is currently 0.7 days. Currently, […]

StockNews.com upgraded shares of OpGen (NASDAQ:OPGN – Get Rating) to a sell rating in a report released on Friday morning. OpGen Stock Performance NASDAQ:OPGN opened at $1.33 on Friday. The firm has a market cap of $3.56 million, a PE ratio of -0.09 and a beta of -0.22. OpGen has a fifty-two week low of […]